Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by FRANKS, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRANKS, A. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 126, No. 1: 112-117
Copyright © 1987 by The Johns Hopkins University School of Hygiene and Public Health

research-article

CIGARETTE SMOKING AND THE RISK OF EPITHELIAL OVARIAN CANCER1

ADELE L. FRANKS, NANCY C. LEE, JULIETTE S. KENDRICK, GEORGE L. RUBIN, PETER M. LAYDE and THE CANCER AND STEROID HORMONE STUDY GROUP 2

Reprint requests to Dr. Adele L. Franks

Cigarette smoking may affect each of the currently proposed mechanisms of ovarian carcinogenesis. Whether cigarette smoking has any effect on the development of ovarian cancer has not been adequately evaluated. To study this issue, the authors examined data from the Cancer and Steroid Hormone Study, a multicenter, case-control study of gynecologic cancers conducted between December 1, 1980, and December 31, 1982, in eight geographic areas of the United States. This analysis utilized data on 494 women with newly diagnosed epithelial ovarian cancer and 4,238 population-based control women 20–54 years of age. There was no association of epithelial ovarian cancer with dose of cigarette smoking, age smoking started, time since smoking started, or time since smoking last occurred. Simultaneous adjustment for age, parity, history of oral contraceptive use, and other potentially confounding factors did not alter these results.

ovarian neoplasms; smoking

1 From the Division of Reproductive Health, Center for Health Promotion and Education, Centers for Disease Control, Atlanta, GA 30333.

2 The Cancer and Steroid Hormone Study Group: Principal Investigator-George L. Rubin; Project Director-Phyllis A. Wingo; Project Associates-Nancy C. Lee, Michele G. Mandel, Herbert B. Peterson. Data Collection Centers Principal Investigators: Atlanta- Raymond Greenberg; Connecticut-J. Wister Meigs, W. Douglas Thompson; Detroit-G. Marie Swanson; Iowa-Elaine Smith; New Mexico-Charles Key, Dorothy Pathak; San Francisco-Donald Austin; Seattle-David Thomas; Utah-Joseph Lyon, Dee West Pathology Review Principal Investigators: Fred Gor-stein, Robert McDivitt, Stanley J. Robboy. Project Consultants: Lonnie Burnett, Robert Hoover, Peter M. Layde, Howard W. Ory, James J. Schlesselman, David Schottenfeld, Bruce Stadel, Linda A. Webster, Colin White. Pathology Consultants: Walter Bauer, William Christopherson, Deborah Gereell, Robert Kunnan, Allen Paris, Frank Vellios.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.